Actionsandprograms againstpaininFrance
FrançoisMeyer,MD Head,HTADivision HauteAutorité deSanté,France DIAEuromeeting2011! Geneva
Actionsandprograms againstpaininFrance FranoisMeyer,MD - - PowerPoint PPT Presentation
Actionsandprograms againstpaininFrance FranoisMeyer,MD Head,HTADivision HauteAutorit deSant,France DIAEuromeeting2011! Geneva 01 Publicactions Before2006
Actionsandprograms againstpaininFrance
FrançoisMeyer,MD Head,HTADivision HauteAutorité deSanté,France DIAEuromeeting2011! Geneva
Publicactions Before2006
Fightagainstpain: PublicactioninFrance(1)
chronicpain
! "
actions
2004:Surveyofemergencymanagementof acutepaininpre!hospitalsettinginFrance
IntensiveCareUnits(MICU)physiciansin severeacutepain(SAP)management.
physiciansin360unitsinFrance
+,"'-'.*
2004Surveyofmanagementofacutepain! Resultsandconclusions
)17%.
)14%.
!)6% 28%.
inout!of!hospitalsetting,bothforpainassessment andtreatment.Therewerefewlocalguidelinesto
+,"'-'.*
Whatchanges since2006?
NewPublicinstitutionsatnationaland regionallevel
: National French Health Authority Independentpublicscientificbody
%%!(()9 :
/)4!
!
2006:Thirdministerialactionplan
! "
)?!)"
,!) ,)"
?"
@!"
2006:Thirdministerialactionplan
Fourpriorities
(children,elderlyandendoflifeperiod);
pharmacologicmethods
Restructuringofthecarepathways
##<B
B
!) B
!"
HowcanHAScontributetotheplan?
Cooperations
jointactionplans
F 4'/-9( &'4"""
!
(! !"
Appropriatecarepathwaysforpatients withchronicpain
B
'"
TheroleofHealth Technology Assessment (HTA)
Marketing Authorisation Access to reimbursement
CEPS
Economic Committee for Healthcare Products
UNCAM
Ministry of Health,
L I S T I N G Criteria: ► Actual benefit (SMR) ►Clinicaladdedvalue (ASMR) Criteria: ►Pharmaceutical quality ►Efficacy ►Safety
Transparency Committee Guidance Decision
; !
(
Clinicaleffectiveness G!
&! >)
& > '&. 1 ! ' ! 1) .)
Criteria Results P R I C I N G
HTA:HASGuidance
Ministry Economic Committee Relativeeffectiveness:
;!! @J
Initialassessment:FromHTAtodecision makingonpriceandreimbursement
6 6
InternationalcooperationonHTA
HASinternal assessors
HAS Transparency Committee
HAS Guidance
Reviewof availabledata
“ ASSESSMENT” “ APPRAISAL”
Dossierfrom Pharma! ceutical Company Literature
Economic Committee ! Ministryof Health ! NHIfunds
Pricing and Decision
< <
InternationalcooperationonHTA
HASinternal assessors
HAS Transparency Committee
HAS Guidance
Reviewof availabledata
“ ASSESSMENT” “ APPRAISAL”
Dossierfrom Pharma! ceutical Company Literature
Economic Committee ! Ministryof Health ! NHIfunds
Pricing and Decision
Theuseofopioidsinchronicnon cancerpain(Afssapsrecommendations)
notapplytoallchronicpainsyndromes,
Drugandnon!drugtherapies
VariousproductionsofHAS
assessment:
.9 '4
http://www.has!sante.fr